Stefano Jaconi

R&D specialist part of Biopharmaceutical Product Development Team at SwissBiotechSolutions Company. Responsible of downstream process of recombinant monoclonal antibodies, preclinical developability assessment and Quality Control (QC) by UHPLC of therapeutical monoclonal antibodies Critical Quality Attributes (CQA). Skills & Abilities Demonstrated strong experience in protein engineering and antibodies technologies (Phage display platform builder of mAbs libraries in Fab and scFv format, upstream and downstream processing of mAbs) acquired in pharma and biotech companies (> 15 years). Technology transfer. Problem solver. Overall responsibility of Sanger DNA sequencing Service at MerckSerono Geneva during more than 10 years and hands on in Next Generation Sequencing, human libraries preparation and sequencing (Illumina & Ion PGM System Thermo Fisher Scientific) at CHUV Lausanne. Extensive experience in biochemistry and molecular biology acquired in Different Academics Research Labs of Geneva University Hospitals and Geneva University Medical Center (+17 years) Mouse and human adult and pluripotent stem cell culture and differentiation toward many cell phenotypes. Cell line engineering and gene expression analysis by real-time qPCR. Now formal CEO-CSO-CFO and Founder of SwissBiotechSolutions Company based in Lugano Meteopolitan Area, Zurich Switzerland and Dubai soon.